| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 1.11e-05 | 7 | 138 | 3 | GO:0034988 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TBX15 ZEB1 SALL3 FOXO6 KLF14 E2F7 ZNF581 SOX8 PGR KLF16 HOXC4 VENTX NEUROD1 SALL2 ZBTB32 KLF1 ZNF358 HES7 PHOX2B PROX1 FOXJ1 | 1.27e-04 | 1244 | 138 | 21 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TBX15 ZEB1 SALL3 FOXO6 KLF14 E2F7 ZNF581 SOX8 PGR KLF16 HOXC4 VENTX NEUROD1 SALL2 ZBTB32 KLF1 ZNF358 HES7 PHOX2B PROX1 FOXJ1 | 1.71e-04 | 1271 | 138 | 21 | GO:0000987 |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 3.92e-04 | 21 | 138 | 3 | GO:0034987 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | TBX15 ZEB1 SALL3 FOXO6 KLF14 E2F7 ZNF581 SOX8 PGR KLF16 HOXC4 VENTX NEUROD1 SALL2 ZBTB32 KLF1 EHMT2 ZNF358 HES7 PHOX2B PROX1 FOXJ1 | 4.24e-04 | 1459 | 138 | 22 | GO:0000977 |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 1.60e-05 | 8 | 138 | 3 | GO:0001812 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 2.39e-05 | 9 | 138 | 3 | GO:0001810 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 3.40e-05 | 10 | 138 | 3 | GO:0001798 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 3.40e-05 | 10 | 138 | 3 | GO:0016068 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 3.40e-05 | 10 | 138 | 3 | GO:0002894 | |
| GeneOntologyBiologicalProcess | somatic sensory system development | 4.44e-05 | 2 | 138 | 2 | GO:0160038 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte mediated immunity | 4.59e-05 | 30 | 138 | 4 | GO:0002888 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 4.65e-05 | 11 | 138 | 3 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 4.65e-05 | 11 | 138 | 3 | GO:0002892 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 7.98e-05 | 13 | 138 | 3 | GO:0001788 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 1.26e-04 | 15 | 138 | 3 | GO:0001794 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 1.26e-04 | 15 | 138 | 3 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 1.26e-04 | 15 | 138 | 3 | GO:0002445 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZEB1 PPRC1 KLF14 MED14 E2F7 AKIRIN2 SOX8 PGR HOXC4 VENTX NEUROD1 SALL2 KLF1 PKD2 MEPCE RNF10 PHOX2B AGRN MAML3 MIR9-1HG PROX1 FOXJ1 | 1.37e-04 | 1390 | 138 | 22 | GO:0045944 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | TBX15 SHROOM3 ZEB1 E2F7 AKIRIN2 SOX8 HOXC4 SALL2 CSF2 KLF1 ZNF358 HES7 DLL3 PKD2 ANKRD11 DMBT1 PROX1 | 1.60e-04 | 929 | 138 | 17 | GO:0009792 |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 1.86e-04 | 17 | 138 | 3 | GO:0002866 | |
| GeneOntologyBiologicalProcess | embryo development | TBX15 SHROOM3 ZEB1 ACD E2F7 AKIRIN2 EYA2 SOX8 CCDC39 HOXC4 NEUROD1 SALL2 TENM4 CSF2 KLF1 ZNF358 HES7 DLL3 PKD2 ANKRD11 DMBT1 PROX1 | 2.20e-04 | 1437 | 138 | 22 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 2.63e-04 | 19 | 138 | 3 | GO:0002883 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid precursor protein biosynthetic process | 2.64e-04 | 4 | 138 | 2 | GO:0042986 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 9.72e-05 | 14 | 138 | 3 | GO:0071735 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 1.79e-04 | 17 | 138 | 3 | GO:0042571 | |
| HumanPheno | Abdominal situs inversus | 3.94e-05 | 142 | 35 | 7 | HP:0003363 | |
| HumanPheno | Situs inversus totalis | 3.94e-05 | 142 | 35 | 7 | HP:0001696 | |
| HumanPheno | Abnormal spatial orientation of the cardiac segments | 3.94e-05 | 142 | 35 | 7 | HP:0011534 | |
| HumanPheno | Abnormality of abdominal situs | 3.94e-05 | 142 | 35 | 7 | HP:0011620 | |
| HumanPheno | Heterotaxy | 4.51e-05 | 145 | 35 | 7 | HP:0030853 | |
| HumanPheno | Abnormal pulmonary thoracic imaging finding | 7.51e-05 | 157 | 35 | 7 | HP:0031983 | |
| HumanPheno | Dextrocardia | 8.14e-05 | 159 | 35 | 7 | HP:0001651 | |
| HumanPheno | Abnormal anatomic location of the heart | 8.47e-05 | 160 | 35 | 7 | HP:0004307 | |
| HumanPheno | Anomalous pulmonary venous return | 2.25e-04 | 83 | 35 | 5 | HP:0010772 | |
| MousePheno | absent memory B cells | 2.10e-06 | 4 | 114 | 3 | MP:0008094 | |
| Domain | Ser/Thr_kinase_C | 5.03e-05 | 2 | 133 | 2 | IPR022708 | |
| Domain | DUF3543 | 5.03e-05 | 2 | 133 | 2 | PF12063 | |
| Domain | Ser/Thr_kin_STPK_Ulk-1/2 | 5.03e-05 | 2 | 133 | 2 | IPR016237 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SHROOM3 ABCA2 TBKBP1 SH3RF1 PPRC1 INPP5E MED14 IRS1 KCNH3 ZNF503 PPP1R26 ANKRD11 RIPOR1 HMGXB3 ULK1 LTBP4 ULK2 AGRN ARAP1 BAHCC1 | 3.80e-08 | 1105 | 145 | 20 | 35748872 |
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 2.83e-07 | 4 | 145 | 3 | 113776 | |
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 2.83e-07 | 4 | 145 | 3 | 11812141 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6794027 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 2.83e-07 | 4 | 145 | 3 | 2510996 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 2.83e-07 | 4 | 145 | 3 | 1754385 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 2.83e-07 | 4 | 145 | 3 | 19050247 | |
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 2.83e-07 | 4 | 145 | 3 | 30287618 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 7892607 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 4565406 | ||
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 2.83e-07 | 4 | 145 | 3 | 25363774 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 20621099 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 2.83e-07 | 4 | 145 | 3 | 12414967 | |
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 2.83e-07 | 4 | 145 | 3 | 8438159 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 4098598 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6253932 | ||
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 2.83e-07 | 4 | 145 | 3 | 6769752 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 2.83e-07 | 4 | 145 | 3 | 6803173 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6264445 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 2.83e-07 | 4 | 145 | 3 | 25867470 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 1542303 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 9725203 | ||
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 2.83e-07 | 4 | 145 | 3 | 9126488 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 8452816 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 4831970 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 7439686 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6278424 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 35133976 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 8099342 | ||
| Pubmed | Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation. | 2.83e-07 | 4 | 145 | 3 | 32006024 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 12209645 | ||
| Pubmed | Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. | 2.83e-07 | 4 | 145 | 3 | 117549 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 116231 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 25451975 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 2.83e-07 | 4 | 145 | 3 | 6283537 | |
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 2.83e-07 | 4 | 145 | 3 | 6801765 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6306571 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 1672339 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 2.83e-07 | 4 | 145 | 3 | 1713710 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6777755 | ||
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 2.83e-07 | 4 | 145 | 3 | 9103199 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6297797 | ||
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 2.83e-07 | 4 | 145 | 3 | 98524 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 38268239 | ||
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 2.83e-07 | 4 | 145 | 3 | 6799207 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6787604 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6170065 | ||
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 2.83e-07 | 4 | 145 | 3 | 19703988 | |
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 2.83e-07 | 4 | 145 | 3 | 6767246 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 12051834 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 8683112 | ||
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 2.83e-07 | 4 | 145 | 3 | 807855 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 4166666 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 26201558 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6249338 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6804950 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 2.83e-07 | 4 | 145 | 3 | 19592272 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 10720538 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 24752300 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 15699144 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 2513486 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 36763580 | ||
| Pubmed | Independent immunoglobulin class-switch events occurring in a single myeloma cell line. | 2.83e-07 | 4 | 145 | 3 | 3921826 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 6262729 | ||
| Pubmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. | 2.83e-07 | 4 | 145 | 3 | 26683050 | |
| Pubmed | Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. | 2.83e-07 | 4 | 145 | 3 | 6766534 | |
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 7.05e-07 | 5 | 145 | 3 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 7.05e-07 | 5 | 145 | 3 | 6770027 | |
| Pubmed | Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. | 7.05e-07 | 5 | 145 | 3 | 7704573 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 7.05e-07 | 5 | 145 | 3 | 20031218 | |
| Pubmed | A novel allele for inducible Cre expression in germinal center B cells. | 7.05e-07 | 5 | 145 | 3 | 30359469 | |
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 9834201 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 103631 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 33163250 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 37310381 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 36853944 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 23423996 | ||
| Pubmed | The disulphide bridges of a mouse immunoglobulin G1 protein. | 7.05e-07 | 5 | 145 | 3 | 5073237 | |
| Pubmed | Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. | 7.05e-07 | 5 | 145 | 3 | 35044826 | |
| Pubmed | Sequential class switching is required for the generation of high affinity IgE antibodies. | 7.05e-07 | 5 | 145 | 3 | 22249450 | |
| Pubmed | The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program. | 7.05e-07 | 5 | 145 | 3 | 26620759 | |
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 32640012 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 32229726 | ||
| Pubmed | Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation. | 7.05e-07 | 5 | 145 | 3 | 34539636 | |
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 3031474 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 33025844 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 36779803 | ||
| Pubmed | Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. | 7.05e-07 | 5 | 145 | 3 | 6798155 | |
| Pubmed | IgG1 cytoplasmic tail is essential for cell surface expression in Igβ down-regulated cells. | 7.05e-07 | 5 | 145 | 3 | 24548411 | |
| Pubmed | Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. | 7.05e-07 | 5 | 145 | 3 | 6781756 | |
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 27167731 | ||
| Pubmed | Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). | 7.05e-07 | 5 | 145 | 3 | 9743367 | |
| Pubmed | Molecular and cellular basis of the retrovirus resistance in I/LnJ mice. | 7.05e-07 | 5 | 145 | 3 | 16301663 | |
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 9707605 | ||
| Pubmed | 1.41e-06 | 6 | 145 | 3 | 27457619 | ||
| Pubmed | 1.41e-06 | 6 | 145 | 3 | 30705065 | ||
| Pubmed | 1.41e-06 | 6 | 145 | 3 | 27769169 | ||
| Pubmed | PLC-gamma2 is essential for formation and maintenance of memory B cells. | 1.41e-06 | 6 | 145 | 3 | 19273623 | |
| Pubmed | Organization of the constant-region gene family of the mouse immunoglobulin heavy chain. | 1.41e-06 | 6 | 145 | 3 | 6804095 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | DCAF15 TICAM1 KLF16 MIDN MVB12A KLF1 ZFR2 ZNF358 SUGP1 MAST3 | 2.37e-04 | 797 | 145 | 10 | chr19p13 |
| GeneFamily | CTAGE family | 5.73e-05 | 15 | 93 | 3 | 907 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 1.02e-04 | 18 | 93 | 3 | 624 | |
| GeneFamily | Sterile alpha motif domain containing | 1.10e-03 | 88 | 93 | 4 | 760 | |
| GeneFamily | SH2 domain containing | 1.83e-03 | 101 | 93 | 4 | 741 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.29e-03 | 14 | 93 | 2 | 1095 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZEB1 SALL3 KLF14 ZNF581 ZNF503 KLF16 SALL2 ZBTB32 KLF1 ZNF358 | 3.80e-03 | 718 | 93 | 10 | 28 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.23e-03 | 206 | 93 | 5 | 682 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1 | 5.71e-06 | 7 | 145 | 3 | MM615 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | TMEM217 TICAM1 RNF19B PRR5 E2F7 IRS1 SOX8 PLEKHN1 ATP10A MEFV PLEKHH1 SLCO5A1 ZBTB32 TRAFD1 SELENOO NKAPL AGRN MIR9-1HG | 7.56e-06 | 973 | 145 | 18 | M41080 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1 | 9.10e-06 | 8 | 145 | 3 | M12486 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.77e-09 | 173 | 145 | 9 | 23e50492bc673aff9df95d97f0b9be4ce57cbf01 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.63e-08 | 169 | 145 | 8 | 9ab34f602d46ce87283d243b81621e8806504f43 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.63e-08 | 169 | 145 | 8 | 89fbafdb4628ce7a90c50398870e0f8ee90cfd91 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.63e-08 | 169 | 145 | 8 | 75d367eb35768d3063096e8866cea649dac3b1bd | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.03e-08 | 170 | 145 | 8 | 7dcb6319ba4d7b258dd0a17449d837800ef46ccc | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.03e-08 | 170 | 145 | 8 | 7377e59fba4bf97ba893ccf6b5e149b5152407be | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.03e-08 | 170 | 145 | 8 | e18211029e9ffad54458fd921f455172aad407c7 | |
| ToppCell | Control-B_cell-Plasmablast|Control / Disease group,lineage and cell class （2021.01.30） | 9.45e-08 | 171 | 145 | 8 | c09afc4b111b2b5acca75177554f6364ee02d37c | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.87e-07 | 158 | 145 | 7 | 17a13c5719eb363f2eb8f1d4e171429c6a1ce1e9 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.87e-07 | 158 | 145 | 7 | 1397078f909338fa5fa3b01748db891e5e3fc9e7 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.87e-07 | 158 | 145 | 7 | e5451cfe67e882eb0c1eca287740f8ab75370abc | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.25e-07 | 159 | 145 | 7 | 6ecc3cb2daa5887b59836842be414a00cdcdaeec | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.25e-07 | 159 | 145 | 7 | 1827493fb464bbddb2ee23f99472cfbcaf57405b | |
| ToppCell | Mild_COVID-19-B_cell-Plasmablast|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.05e-06 | 162 | 145 | 7 | b67f6fb3d7f6093c8ef02398ff8fea4d0fb41a3b | |
| ToppCell | BAL-Control-Lymphocyte-B|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.82e-06 | 176 | 145 | 7 | 7c1ecec45b5fe5e73cbce0fadca726ffd10c0316 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-06 | 183 | 145 | 7 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | Sigmoid-(0)_NK_cell|Sigmoid / shred on region, Cell_type, and subtype | 4.11e-06 | 199 | 145 | 7 | 5be944da7a6c5f6076ed508a64f77d90836becd7 | |
| ToppCell | Sigmoid-NK_cell-NK|Sigmoid / Region, Cell class and subclass | 4.11e-06 | 199 | 145 | 7 | 5aa943ef7a1764ce4e95a7163aaabe2ee89eb870 | |
| ToppCell | Sigmoid-NK_cell|Sigmoid / Region, Cell class and subclass | 4.11e-06 | 199 | 145 | 7 | 653965a8bb09abcab7d275b01d361b7b4e3fdd58 | |
| ToppCell | Sigmoid-(0)_NK_cell-(00)_NK|Sigmoid / shred on region, Cell_type, and subtype | 4.11e-06 | 199 | 145 | 7 | 689e8675d2d40cfb1bd200767a35dcc6664214d9 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.25e-06 | 200 | 145 | 7 | ea1e3eeddbc398ac97863120f7aa3f17569ca12a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 4.25e-06 | 200 | 145 | 7 | 98a994692440cb4f505b050276f0c8022c814a21 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related-Oligodendrocyte/OPC|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.25e-06 | 200 | 145 | 7 | 4a57f2f2dc6e2402ac4772b5cd38e033a6f1adee | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 4.25e-06 | 200 | 145 | 7 | ef222dc4a205d670172dae74990bdb952ac92e5b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.86e-06 | 150 | 145 | 6 | c3ad5fa41eb636a5d691c0268c0f1c32cd0de658 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.86e-06 | 150 | 145 | 6 | 78b8029e71d26f336a46274c8afef3435bf536b9 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 154 | 145 | 6 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 154 | 145 | 6 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.23e-05 | 156 | 145 | 6 | 7e6805ebc7bc2f9c5965321d16922c155719970f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like-IPs_and_early_cortical_neurons|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.23e-05 | 156 | 145 | 6 | 741de05295b2d012ac8576378f37709a97c8fb50 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 1.37e-05 | 159 | 145 | 6 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 1.42e-05 | 160 | 145 | 6 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | 343B-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 164 | 145 | 6 | cf62d34ce9dd220fe61748466c84fd70d9ba697c | |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 164 | 145 | 6 | e00549bc8b3a5566f39031f39d7e698b0b107a7f | |
| ToppCell | lymphoid-B_cell-pro-B|lymphoid / Lineage, cell class and subclass | 1.69e-05 | 165 | 145 | 6 | 8126c2f7810fc6e09b18783aadf6434ae12b0514 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-05 | 166 | 145 | 6 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 166 | 145 | 6 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-05 | 166 | 145 | 6 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-05 | 166 | 145 | 6 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.01e-05 | 170 | 145 | 6 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.07e-05 | 171 | 145 | 6 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 | |
| ToppCell | ICU-SEP-Lymphocyte-B-B_intermediate|ICU-SEP / Disease, Lineage and Cell Type | 2.07e-05 | 171 | 145 | 6 | 2e44bf6f3d90193e7cadcac48bb852bd632a81bc | |
| ToppCell | Influenza_Severe-B_intermediate|World / Disease group and Cell class | 2.07e-05 | 171 | 145 | 6 | 4d33e1dc1efc423dbdd5f4cca6d6440a68add8d0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.07e-05 | 171 | 145 | 6 | a2938e56cb5749004317798dc7ac0f0c2d4d8ae0 | |
| ToppCell | Influenza_Severe-B_intermediate|Influenza_Severe / Disease group and Cell class | 2.29e-05 | 174 | 145 | 6 | 4276bdaac53aebd3084323a90ecde572d3177446 | |
| ToppCell | Healthy_donor-Plasmablast|World / disease group, cell group and cell class (v2) | 2.36e-05 | 175 | 145 | 6 | 5293e00fda63a291aa393bdf82ebd4b80265049f | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 176 | 145 | 6 | 2e9073166da4d9fae70ba4f3fdcad35523caf7cd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-05 | 177 | 145 | 6 | 0417460bdb012bc43d7254377fa53d79cdab3f34 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.52e-05 | 177 | 145 | 6 | 95760841b3f085d38c4926b258a33563d93a2016 | |
| ToppCell | Healthy-Plasmablast|Healthy / disease group, cell group and cell class | 2.52e-05 | 177 | 145 | 6 | 4ff75c609ac9edf7a94bda42eb7124c559e8b6aa | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.68e-05 | 179 | 145 | 6 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-05 | 180 | 145 | 6 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.77e-05 | 180 | 145 | 6 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 181 | 145 | 6 | f1d88b83a13acd1c8e6b9ff8bd0acaff3650ceef | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-05 | 181 | 145 | 6 | 70cd612706640d8ebf0e047582b1daa2c1121526 | |
| ToppCell | severe_influenza-B_intermediate|World / disease group, cell group and cell class (v2) | 2.94e-05 | 182 | 145 | 6 | e633a908a2fb30ed362cf22fbb8d6839f31f1751 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-05 | 183 | 145 | 6 | 82fe14fc7039415de41bdfd615a1380bed99f560 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 3.13e-05 | 184 | 145 | 6 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | CTRL-Lymphoid|CTRL / Disease state, Lineage and Cell class | 3.13e-05 | 184 | 145 | 6 | 26fb2c4e6cb9950c27eb15428e7e74e5abb4397d | |
| ToppCell | Healthy/Control-B_memory|World / Disease group and Cell class | 3.13e-05 | 184 | 145 | 6 | 9e1879d86b535ede9b47deb0752e291f987a5d5e | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 3.33e-05 | 186 | 145 | 6 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 3.43e-05 | 187 | 145 | 6 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | severe_influenza-B_intermediate|severe_influenza / disease group, cell group and cell class (v2) | 3.43e-05 | 187 | 145 | 6 | d6db8595aa72fdabc4a056ba6ce09876868a66d5 | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.53e-05 | 188 | 145 | 6 | de7cb273899d0e0748c85f45c6b5e7f0642ab057 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.53e-05 | 188 | 145 | 6 | 18d16e3f095a109b6a690f46fe7fcd5674c3636b | |
| ToppCell | Healthy/Control-B_memory|Healthy/Control / Disease group and Cell class | 3.53e-05 | 188 | 145 | 6 | 3aff07f77b2b15e7a30e47b30115178abe64474e | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.53e-05 | 188 | 145 | 6 | f4734d5b703678670ece204a0519cf015e180a6e | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.64e-05 | 189 | 145 | 6 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma|bone_marrow / Manually curated celltypes from each tissue | 3.64e-05 | 189 | 145 | 6 | dceb011216deb4ffd830144a53c635c05dff5ec5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.64e-05 | 189 | 145 | 6 | ac0203f17b481d608587113ea2de0f383b29ed27 | |
| ToppCell | Healthy_donor-B_memory|Healthy_donor / disease group, cell group and cell class (v2) | 3.75e-05 | 190 | 145 | 6 | 46104a521f00d399315deca86699cb261b2795d6 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 3.97e-05 | 192 | 145 | 6 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.97e-05 | 192 | 145 | 6 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.97e-05 | 192 | 145 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.97e-05 | 192 | 145 | 6 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 192 | 145 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | VE-naiveBc-|VE / Condition, Cell_class and T cell subcluster | 3.97e-05 | 192 | 145 | 6 | bca2aec4811627225fccd92abe2f3b1ba729c9ce | |
| ToppCell | VE-naiveBc|VE / Condition, Cell_class and T cell subcluster | 3.97e-05 | 192 | 145 | 6 | 87cdda9a170f6f2fa56d0ed1d3fd2f93bfe09aa1 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.21e-05 | 194 | 145 | 6 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.21e-05 | 194 | 145 | 6 | cbc4b6422777117e4123804168c23f19d1b79486 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-05 | 195 | 145 | 6 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.58e-05 | 197 | 145 | 6 | 0d38d126b1e653398426255e95449f1150eac1b0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.58e-05 | 197 | 145 | 6 | bb35a2b7320fda92e9cd42f536b7bd54e3a73a32 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Plasma_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.58e-05 | 197 | 145 | 6 | 7ffb373d5b72c67e4816f14ea9a7a2024dc7a93a | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.58e-05 | 197 | 145 | 6 | 2e76e9ebd8702bfeefd396cbf5114eee0f24c19b | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.58e-05 | 197 | 145 | 6 | 207fce47e547fafbaf64a22efe3488e74bf19bed | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_intermediate|Influenza_Severe / Disease, condition lineage and cell class | 4.71e-05 | 198 | 145 | 6 | ab622fee61714471af3a7be0af356e8a484dcaff | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.71e-05 | 198 | 145 | 6 | 50dfe6efca76ea9683a19b6bff59cb5030d346f1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-05 | 199 | 145 | 6 | ce699726ac4825c65bf934cb9a76202ad7340596 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-05 | 199 | 145 | 6 | a76aa30fb264bdcbc0cb09113f814fc5a89e7319 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-B-B_memory|Multiple_Sclerosis / Disease, condition lineage and cell class | 4.85e-05 | 199 | 145 | 6 | ae2979c0d2711580863d3b751f6ff1e3abdfd90e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-05 | 199 | 145 | 6 | 1761669ec514fdb4175042f11b9a31fa5687fc2b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-05 | 199 | 145 | 6 | a816b0eed80530113b7e720bbd2311a544ed8ed1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related-Oligodendrocyte/OPC|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.98e-05 | 200 | 145 | 6 | 7557ea33c3d080d0fa4ca0c2703279932d01e6d0 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 200 | 145 | 6 | 56f1f007ba8c9188a4b10e52744f1e50dc0f155a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.98e-05 | 200 | 145 | 6 | 3dcaeb9f1e387784c299bfe0da1516598f82edf5 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.98e-05 | 200 | 145 | 6 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Neuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.98e-05 | 200 | 145 | 6 | b5019b9d48f32cffd4645a5c0f3e0ac504ea8019 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.79e-05 | 126 | 145 | 5 | 518a6e4919981b556ce6b451a91270dba976bc75 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-05 | 129 | 145 | 5 | e7a15f98c3e6e4ee317e21958be3e413e3acd101 | |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; MCF7; HT_HG-U133A | ABCA2 GIT1 RNF19B POM121L2 ATP10A DLL3 CROCC LTBP4 KLRB1 BAHCC1 | 4.84e-07 | 198 | 142 | 10 | 2797_UP |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.56e-06 | 199 | 142 | 9 | 7439_UP | |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; HL60; HT_HG-U133A | 4.56e-06 | 199 | 142 | 9 | 2503_DN | |
| Disease | immunoglobulin G measurement | 2.17e-05 | 2 | 138 | 2 | EFO_0020465 | |
| Disease | spondylocostal dysostosis (implicated_via_orthology) | 6.49e-05 | 3 | 138 | 2 | DOID:0050568 (implicated_via_orthology) | |
| Disease | Primary Ciliary Dyskinesia | 6.99e-05 | 47 | 138 | 4 | C4551720 | |
| Disease | sortilin measurement | 1.29e-04 | 4 | 138 | 2 | EFO_0600000 | |
| Disease | Autosomal recessive spondylocostal dysostosis | 1.29e-04 | 4 | 138 | 2 | cv:CN043670 | |
| Disease | SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 3 | 2.15e-04 | 5 | 138 | 2 | C1853296 | |
| Disease | Spondylocostal dysostosis | 2.15e-04 | 5 | 138 | 2 | cv:C0265343 | |
| Disease | SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 2 | 2.15e-04 | 5 | 138 | 2 | C1837549 | |
| Disease | Jarcho-Levin syndrome | 3.22e-04 | 6 | 138 | 2 | C0265343 | |
| Disease | Hidradenitis Suppurativa | 4.49e-04 | 7 | 138 | 2 | C0162836 | |
| Disease | Joubert syndrome (implicated_via_orthology) | 4.49e-04 | 7 | 138 | 2 | DOID:0050777 (implicated_via_orthology) | |
| Disease | smoking behavior, BMI-adjusted waist-hip ratio | 7.23e-04 | 86 | 138 | 4 | EFO_0004318, EFO_0007788 | |
| Disease | Polycystic Kidney, Autosomal Dominant | 7.65e-04 | 9 | 138 | 2 | C0085413 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 7.65e-04 | 9 | 138 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | Joubert syndrome (is_implicated_in) | 9.53e-04 | 10 | 138 | 2 | DOID:0050777 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement | 1.44e-03 | 260 | 138 | 6 | EFO_0008317 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.90e-03 | 14 | 138 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 1.90e-03 | 14 | 138 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Sarcoma, Spindle Cell | 1.90e-03 | 14 | 138 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 1.90e-03 | 14 | 138 | 2 | C0205944 | |
| Disease | vital capacity | TBX15 EPHB3 FAM184B SHROOM3 POM121L2 EYA2 PRIMA1 KCNH3 PTPDC1 CSF2 HES7 RIPOR1 LTBP4 TNS1 | 2.00e-03 | 1236 | 138 | 14 | EFO_0004312 |
| Disease | level of C-X-C motif chemokine 3 in blood serum | 2.19e-03 | 15 | 138 | 2 | OBA_2041208 | |
| Disease | age at first birth measurement | 2.47e-03 | 120 | 138 | 4 | EFO_0009101 | |
| Disease | serum alanine aminotransferase measurement | SHROOM3 KLF14 TNFRSF10B EYA2 TRAFD1 TENM4 DIAPH1 SUGP1 PSRC1 MAST3 ARAP1 | 2.64e-03 | 869 | 138 | 11 | EFO_0004735 |
| Disease | body fat percentage, type 2 diabetes mellitus | 2.82e-03 | 17 | 138 | 2 | EFO_0007800, MONDO_0005148 | |
| Disease | alcoholic liver cirrhosis | 2.82e-03 | 17 | 138 | 2 | EFO_1000802 | |
| Disease | diffuse plaque measurement | TBX15 SHROOM3 RNF19B PPP1R26 TMEM78 TENM4 EHMT2 DMBT1 LINC00114 TNS1 | 3.06e-03 | 758 | 138 | 10 | EFO_0010699 |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 3.16e-03 | 18 | 138 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 3.52e-03 | 19 | 138 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.83e-03 | 220 | 138 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | skin pigmentation measurement | 3.98e-03 | 137 | 138 | 4 | EFO_0007009 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.13e-03 | 224 | 138 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | Neoplastic Cell Transformation | 4.19e-03 | 139 | 138 | 4 | C0007621 | |
| Disease | triglyceride measurement, body fat percentage | 4.30e-03 | 21 | 138 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | Sarcoma | 4.30e-03 | 21 | 138 | 2 | C1261473 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 4.53e-03 | 229 | 138 | 5 | EFO_0004639, EFO_0008317 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTLSSARPREGSCPS | 71 | Q6XXX2 | |
| CPASSPGPGSRVRSA | 1021 | Q9P281 | |
| TGVPTPTSVLSCPSY | 1701 | Q6UB99 | |
| TPVPTAPTSACSPSF | 1746 | Q6UB99 | |
| CSPSPLGRPSSETRA | 521 | Q8IX94 | |
| CSPSPLGRPSSETRA | 521 | P0CG41 | |
| CSPSPLGRPSSETRA | 521 | A4FU28 | |
| DTSPCPNSPVFRTGS | 356 | O75815 | |
| SFSPADVAPGPICSA | 86 | Q8N9P6 | |
| RCAPLSAPTSAAASP | 26 | Q53H80 | |
| RTRLPPAGSTPSFCH | 16 | P22570 | |
| TPITPASLAGCYSAP | 21 | P54756 | |
| SSVATPGPPVERASC | 1091 | O00468 | |
| DSRSSSPEPACGTPR | 121 | Q8TAB5 | |
| PFTPSSPLLSCSQEG | 566 | Q9Y2X7 | |
| FPSSPSKGGSCPSRA | 116 | Q96KQ7 | |
| SGPIFSSPCTSPSEQ | 976 | Q4L235 | |
| PVSTSSCLSPRGPSS | 251 | Q9NYJ7 | |
| CISSPPSLPGGTAIS | 626 | O60610 | |
| GVTIATSPSPASCPA | 421 | Q9H694 | |
| PRPPGSTSHCGISTR | 61 | Q13536 | |
| PATDGSISAPPSVCS | 726 | P78312 | |
| SAPLSPSSTGTCPRL | 471 | Q5T6C5 | |
| SLCPPSTSTASGRRP | 956 | O60312 | |
| PRAHPSPGSTLFTCS | 96 | Q16671 | |
| FPASSSLVGSPSRPS | 911 | Q9UFE4 | |
| PGPCRTESPSNSLAA | 866 | Q7Z5Q5 | |
| ACPGTPATTPFTFTT | 1301 | Q9HC84 | |
| SSPDDSIGCLSFSPP | 36 | P78406 | |
| VTDAASPSGPSPSCL | 81 | Q9H714 | |
| TKPSPASGFSPSVQC | 126 | Q92542 | |
| ADEPSSPLLSPGCTS | 746 | Q9ULD8 | |
| SPSDSLPCSLAGSPA | 226 | Q9BXK1 | |
| ARPSSSGPPFSTVST | 376 | Q96JK9 | |
| ARPTVCSPSSQPSLG | 86 | Q9NTI7 | |
| SCFPASLTASRGPIA | 521 | Q7L2J0 | |
| ESPALACSTPATPSG | 46 | Q9NRR6 | |
| STSPSCVTAPCAPRP | 421 | O76015 | |
| ITTSPSLDPSPSCGR | 1001 | Q9ULE4 | |
| ATSTPVSLGSSPPCR | 51 | Q96KR4 | |
| CVPVFPGRGSSPSSN | 636 | Q5VYM1 | |
| RAPGPSQSFCSSPIL | 801 | Q5VYM1 | |
| QGCFSSPTEPPVSVS | 1126 | Q12766 | |
| SPASALSPALGSRCP | 281 | A8MYZ6 | |
| SADSACTTVPSPPRG | 331 | P54753 | |
| TPSADSRPSCIGAAP | 86 | Q8N3J3 | |
| SVTGRPPDTAASPRC | 301 | O15553 | |
| NSRTPRSPLDCGSSP | 541 | A2A3K4 | |
| PTCNLFPASKSPASS | 176 | Q6PGN9 | |
| GPVAFHSSPSVRCPS | 911 | P35568 | |
| TSQTLPPKPFSCGRS | 311 | Q68DK7 | |
| PSCLGSPPLRSASDN | 356 | Q14451 | |
| SAPPPRGFSAISCTV | 21 | Q96EY5 | |
| SSPSGALRAPSPASF | 1051 | O60244 | |
| PGPLCSSFSTPSTPQ | 96 | O43182 | |
| ASAFAPPRSSPCASS | 336 | P06401 | |
| PRVVDGTPCSPDSSS | 636 | O75173 | |
| SPRRGPSPACSDSST | 506 | Q5TZA2 | |
| TVACSISAPARSPSP | 11 | P04141 | |
| PPFCLPASSLGVATS | 391 | Q9H5Z6 | |
| TSGARPDGSCSLPAP | 41 | Q494R0 | |
| APGPATSPSFLSCLG | 226 | Q13351 | |
| VGPSSGQLPSFSVPC | 731 | Q96AV8 | |
| FSSPVCLRSPATPSD | 441 | Q8NCQ5 | |
| SLCEPAPLSGASASP | 96 | P09017 | |
| PTSSCTSRSAPPGLQ | 91 | Q92949 | |
| ASSPPGRAPLSSCSE | 1236 | Q9BZC7 | |
| ASTAPGAEASPSPCI | 46 | Q66PJ3 | |
| ASLFSSLASPCPGSP | 166 | Q8TF76 | |
| CPRSASASPLTPCSV | 361 | Q3KQU3 | |
| SRDSSPSRDPSPVCG | 931 | O60307 | |
| RCVPPRTSAGTFPGS | 1131 | Q8N2S1 | |
| TCAYTTPGPPRALTT | 31 | Q9H4A9 | |
| SSGFSDPIPCSVQTP | 111 | Q8TD94 | |
| ASTKGPSVFPLAPCS | 1 | P01859 | |
| PSVFPLAPCSRSTSE | 6 | P01859 | |
| ASTKGPSVFPLAPCS | 1 | P01860 | |
| PSVFPLAPCSRSTSG | 6 | P01860 | |
| ASTKGPSVFPLAPCS | 1 | P01861 | |
| PSVFPLAPCSRSTSE | 6 | P01861 | |
| CSSASLPASPAPRAA | 191 | Q9NQR7 | |
| PPRASARNSCPAGSA | 266 | Q9NQR7 | |
| PLSRSLPPCSNSSSF | 31 | Q96PD2 | |
| SPSLCSPRAGDSGAP | 176 | Q9BYE0 | |
| GTLSTAAPTTSPAPC | 16 | Q8NEQ5 | |
| ICSASQSRPTPSPDT | 1091 | Q9UGM3 | |
| TSVLCFTTPGDGPPS | 946 | Q7Z5N4 | |
| CSPSITSTGLSPFPR | 986 | Q9Y467 | |
| PSPASSECASLSPGL | 556 | Q9BXA9 | |
| APSSLLSPEASPCRN | 1371 | Q5VV67 | |
| PSFCPEAAPARSSGS | 296 | Q66K64 | |
| VSCSPTSGAVPPYSS | 61 | A1KXE4 | |
| YVPASSICPSPLSTS | 186 | O00167 | |
| SPVSSPCRPVSSAAR | 186 | Q504T8 | |
| GSPRSHTAACPSTPR | 686 | Q6ZMZ0 | |
| AGTPAGSRCTTPVPT | 291 | Q9Y6M7 | |
| SVPASDPRSCSSGPA | 501 | Q494U1 | |
| SRSTSGPRPGCQPSS | 466 | O14545 | |
| VATSTDPSCSGFAPP | 51 | Q8WUG5 | |
| RRSASPPTSLPSTCG | 771 | Q5TCX8 | |
| PPTSLPSTCGEASSP | 776 | Q5TCX8 | |
| TFRSSPAPHSGPCPS | 306 | P85299 | |
| RLLSAPAPNSTSCPT | 71 | Q86XR5 | |
| NSSRDSPPECLSPFG | 131 | Q92786 | |
| ASSHLLSPSCSPPTF | 361 | Q96SF7 | |
| PGSPSITFSACSRIG | 686 | Q6AI14 | |
| CRPSLSPTSGDANPA | 46 | Q9H2Y9 | |
| GRCSPSPAPRSTLSG | 21 | Q9BVL4 | |
| LCSTSDPDTPLGAPS | 1466 | Q8TF72 | |
| CGSPSFLTPSPGAER | 1001 | Q5T8A7 | |
| GPRGDTVSASPCSAP | 236 | Q15477 | |
| EARSQPPCSPSGTAS | 6 | P57073 | |
| SCRSLSQPSPSPAGG | 476 | O15079 | |
| PSCSSPTRDSSGVPV | 11 | Q8N5I9 | |
| SCHRPSSPVPLVSDF | 291 | Q96KW2 | |
| PSPGLPATSSCESVL | 56 | Q92502 | |
| LPGLPTSPDSASSAC | 686 | Q7Z6J0 | |
| SPAICSAPATLTPRS | 316 | Q96AP0 | |
| RSCLPPTCFTTPSTA | 121 | Q96P48 | |
| PTCFTTPSTAAPDPV | 126 | Q96P48 | |
| SPPACSAFPRGAISS | 131 | Q9GZX3 | |
| CGARTAPTPAPTCAS | 191 | Q9H7T3 | |
| RSSSGSPPSPQSRCS | 21 | Q5M9Q1 | |
| EALSGSLPPATTCPA | 341 | Q8IWZ8 | |
| SIAPTSCAGNLPSRP | 81 | Q86UC2 | |
| GASARKTPCPSPSTH | 81 | Q8N966 | |
| SPSVAASLSCPVPST | 1346 | Q7Z2Z1 | |
| GSTPPPSCAVRSCLS | 1826 | Q7Z2Z1 | |
| PTSPTGPSVCASSRP | 376 | Q9UPR6 | |
| CLPTTSAPASAPSNG | 161 | O94956 | |
| HCSSPSVTPPFGSLR | 166 | Q8IZW8 | |
| SSSRSSPVSGPPAVC | 286 | Q5TF21 | |
| PCSAHLTPSSLFPSS | 371 | Q8IUC6 | |
| PLSPTASQGSPSFCV | 686 | Q8N5U6 | |
| GAPCSSPGPSLSSVL | 26 | Q7Z404 | |
| SAATTPGSPSLCRHP | 1236 | Q9HBL0 | |
| PVVSPSPLTSFASSC | 1021 | Q6N022 | |
| SPGTPASPCSLSGII | 201 | O14763 | |
| PAVTSLASPPLCFGS | 111 | Q1RN00 | |
| AAASPSPPLSSCSRQ | 71 | Q13563 | |
| CCASSPPALVSPGSF | 446 | Q9ULM0 | |
| SAPSCPGVGASSPRR | 181 | Q6ZRN7 | |
| CSSPSLSASPGSPTR | 311 | P37275 | |
| ACSPRSPQHTPGVFS | 211 | Q8N9P0 | |
| CGSSPSCRFASPPSL | 296 | Q8IYT8 | |
| SATCQPFTPRTGSPS | 216 | Q96F45 | |
| SESPLGTLPCSVPAS | 146 | Q6ZR54 | |
| RPSRPSTSPCCPSSS | 471 | Q9Y2Y4 | |
| RTCRSPEPGPSSSIG | 26 | Q9P0T4 | |
| PTFGSKPCPTRLSSA | 1051 | Q9Y4F4 | |
| SIFTCLSPVPSSAPS | 206 | Q8N7C4 | |
| SPSARPLSTGCPALD | 886 | Q6ZS17 | |
| PIRTTFGATSGCPSL | 46 | Q99453 | |
| SPPSPEVGTIRCASF | 531 | A7MCY6 | |
| CSLNIPGSSDPPTSA | 121 | Q5T7P6 | |
| FSSSRCGASVPIPVP | 421 | O75385 | |
| SSCSGPTHTPRPADF | 26 | O95231 | |
| SSSCLPLASFSPAQP | 191 | Q6ZQT7 | |
| VSCPDPCSPTRGTVS | 531 | Q9NW07 | |
| SSPSSLPRDVCQGSP | 21 | Q12918 | |
| HGVTSFCPTLVTSPP | 101 | Q9Y303 | |
| LTDCTSPSFDGPLSP | 261 | Q13562 |